SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CollaGenex (CGPI) FDA PENDING -- Ignore unavailable to you. Want to Upgrade?


To: Mark T. Heath who wrote (24)3/25/1998 2:20:00 PM
From: Tony J Brice  Respond to of 142
 
FWIW, got this off of briefing.com this afternoon --

Boenning & Scattergood, Inc. Reiterates BUY Recommendation of CollaGenex Pharmaceuticals Inc. (CGPI)

PR Newswire, Wednesday, March 25, 1998 at 12:45

KING OF PRUSSIA, Pa., March 25 /PRNewswire/ -- Boenning & Scattergood
reiterates BUY recommendation on CollaGenex Pharmaceuticals Inc.
(NASDAQ:CGPI) based upon positive meetings with the FDA regarding
Periostat(R). Twelve to eighteen month price target is $18-$23 a share.